Adage Capital Partners
ENSC icon

Adage Capital Partners’s Ensysce Biosciences ENSC Stock Holding History

Adage Capital Partners’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.4K Hold
149,711
– – ﹤0.01% 989
2026
Q1 		$80.6K Hold
149,711
– – ﹤0.01% 941
2025
Q4 		$138K Buy
149,711
+75,000
+100% +$139K ﹤0.01% 888
2025
Q3 		$177K Hold
74,711
– – ﹤0.01% 859
2025
Q2 		$167K Hold
74,711
– – ﹤0.01% 831
2025
Q1 		$191K Buy
74,711
+24,711
+49% +$143K ﹤0.01% 823
2024
Q4 		$407K Buy
+50,000
New +$345K ﹤0.01% 843

Other funds holding ENSC

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Adage Capital Partners's ENSC Position: Q2 2026 in Review

Adage Capital Partners held its Ensysce Biosciences (ENSC) position steady in Q2 2026 at 149,711 shares worth $43.4K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Adage Capital Partners first reported a position in ENSC in Q4 2024 and has held it in 7 quarters since. The position peaked at $407K in Q4 2024. 18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

  • Adage Capital Partners held 149,711 shares of Ensysce Biosciences worth $43.4K as of Q2 2026.
  • Adage Capital Partners left its Ensysce Biosciences share count unchanged in Q2 2026.
  • Ensysce Biosciences made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #989 holding.
  • Adage Capital Partners first reported a position in Ensysce Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Adage Capital Partners's Ensysce Biosciences position peaked at $407K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.